Sort By
-
Lu Yang
Growing evidence points to a link between..
Lu Yang
2013 PCF China Young Investigator in Honor of Stanley Zax
Lu Yang, MD:
West China Hospital, Sichuan University
Mentors:
Qiang Wei, MD and Tianyong Fan, MD
Proposal Title:
Treating inflammation to prevent prostate cancer initiation and progression.
-
Shalini S. Yadav
Growing clinical evidence suggests that a majority..
Shalini S. Yadav
2013 LeFrak Family-PCF Young Investigator
Shalini S. Yadav, PhD:
Mount Sinai School of Medicine
Mentors:
Ashutosh Tewari, MD
Project Title:
Intratumor Heterogeneity (ITH) in Prostate Cancer
-
Daniel Thorek
Treatment of advanced, metastatic prostate cancer, although..
Daniel Thorek
2013 Steve Wynn-PCF Young Investigator
Daniel Thorek, PhD:
Johns Hopkins University
Mentors:
David Scheinberg, MD, PhD and Steve Larson, MD
Project Title:
Alpha-particle therapy by 225Actinium-labeled prostate kallikrein-specific antibody to eradicate advanced disease
-
Nicole Simone
IGF (Insulin-like Growth Factor) receptor is dysregulated..
Nicole Simone
2013 Ben Franklin-PCF Young Investigator
Nicole Simone, MD:
Thomas Jefferson University
Mentors:
Adam Dicker, MD, PhD, Karen Knudsen, PhD and Peter Carroll, MD
Project Title:
Metabolic approaches for targeting multiple components of the IGF-1R pathway in prostate cancer
-
Matthew Schiewer
Deficiencies in the repair of DNA are..
Matthew Schiewer
2013 Ben Franklin-PCF Young Investigator
Matthew Schiewer, PhD:
Thomas Jefferson University
Mentor:
Karen Knudsen, PhD
Project Title:
Determining the translation capacity of the PARP-1/AR axis in prostate cancer
-
Jennifer Rider
Low vitamin D levels in blood have..
Jennifer Rider
2013 Michael & Lori Milken-PCF Young Investigator
Jennifer Rider, ScD:
Harvard School of Public Health
Mentors:
Lorelei Mucci, ScD and Myles Brown, MD
Project Title:
The immunomodulatory and androgen-associated actions of vitamin D in prostate cancer
-
Colin Pritchard
Colin Pritchard
2013 D. Wayne and Anne Gittinger - PCF Young Investigator
Colin Pritchard, MD, PhD:
University of Washington
Mentors:
Peter Nelson, MD
Project Title:
Targeting the ‘Hypermutated Subtype’ of Prostate Cancer: From Mechanism to Implementation of Genomic Testing for Precision Therapy”
-
Niv Papo
Angiogenesis is the process of new blood..
Niv Papo
2013 Joseph Neubauer-PCF Young Investigator
Niv Papo, PhD:
Ben-Gurion University of the Negev (Israel)
Mentor:
Eyal Mishani, PhD
Project Title:
Developing novel dual-specific proteins that target multiple receptors for applications in prostate cancer imaging and therapy
-
Antonina Mitrofanova
Systems biology is a computational-based inter-disciplinary field..
Antonina Mitrofanova
2013 Stanley Zax-PCF Young Investigator
Antonina Mitrofanova, PhD:
Rutgers, The State University of New Jersey
Mentor:
Michael Shen, PhD
Project Title:
A systems biology approach to identify and evaluate novel drug targets for aggressive prostate cancer
-
Rohit Mehra
LncRNAs (long non-coding RNAs) are a form..
Rohit Mehra
2013 Stanley Zax-PCF Young Investigator
Rohit Mehra, MD:
University of Michigan School of Medicine
Mentor:
Arul Chinnaiyan, MD, PhD
Project Title:
Clinicopathological characterization of novel lncRNAs in prostate cancer risk stratification
-
Theodoros Karantanos
Certain oncogenic molecules in prostate cancer cells..
Theodoros Karantanos
2013 David and Judy Fleischer-PCF Young Investigator
Theodoros Karantanos, MD:
MD Anderson Cancer Center
Mentors:
Timothy Thompson, PhD and Christopher Logothetis, MD
Project Title:
The role of aerobic glycolysis in the development of castrate resistant prostate cancer
-
Hao Hu
Dr. Hu’s research program will focus on..
Hao Hu
2013 PCF China Young Investigator in Honor of Stanley Zax
Hao Hu, MD, MBBS:
People’s Hospital, Peking University
Mentors:
Kexin Xu, MD, MBBS and Xiaofeng Wang, MBBS
Project Title:
EMI1 and its role in prostate cancer initiation and progression.
-
Vivek Arora
Preclinical assessment of mechanisms of resistance to..
Vivek Arora
2013 Millennium: The Takeda Oncology Company
Vivek Arora, MD, PhD:
Washington University
Mentor:
Charles Sawyers, MD
Project Title:
Defining strategies to overcome enzalutamide (Xtandi) resistance
-
Jennifer Bishop
Approximately 25% of patients who fail Xtandi..
Jennifer Bishop
2013 Millennium Pharma-PCF Young Investigator
Jennifer Bishop, PhD:
University of British Columbia
Mentors:
Martin Gleave, MD and Amina Zoubeidi, PhD
Project Title:
Regulation of cell plasticity by the androgen receptor: A novel mechanism of enzalutamide (Xtandi) resistance
-
Irfan Asangani
The organization of DNA into super-structures is..
Irfan Asangani
2013 The Republic of Tea-PCF Young Investigator
Irfan Asangani, PhD:
University of Michigan
Mentor:
Arul Chinnaiyan, MD, PhD
Project Title:
Characterization and therapeutic targeting of MMSET in prostate cancer
-
Qi Cao
A family of proteins known as the..
Qi Cao
2013 Michael & Lori Milken-PCF Young Investigator
Qi Cao, PhD:
Houston Methodist Research Institute
Mentor:
Arul Chinnaiyan, MD, PhD
Project Title:
A novel role for Polycomb Group proteins in androgen signaling and prostate cancer
-
Charles Chan
Engraftment of prostate cancer in bone heralds..
Charles Chan
2013 Steve Wynn-PCF Young Investigator
Charles Chan, PhD:
Stanford University School of Medicine
Mentors:
Irving Weissman, MD and Michael Longaker, MD
Project Title:
Identification and therapeutic targeting of cancer stem cell niche interactions in metastatic prostate bone marrow disease
-
Chia-Yi Chu
An unmet medical need is the control..
Chia-Yi Chu
2013 Steve Wynn-PCF Young Investigator
Chia-Yi Chu, PhD:
Cedars-Sinai Medical Center
Mentor:
Leland Chung, PhD
Project Title:
Metastasis-initiating cells (MICs) as predictors of lethal progression of human prostate cancer
-
Michael Evans
Molecular imaging of prostate cancer to determine..
Michael Evans
2013 David H. Koch-PCF Young Investigator
Michael Evans, PhD:
University of California, San Francisco
Mentors:
Charles Sawyers, MD and Jason Lewis, PhD
Project Title:
Exploiting the genetics of advanced prostate cancer for tumor detection and therapy with transferrin-based radionuclides
-
Jason A. Efstathiou
Jason A. Efstathiou
2013 Astellas Scientific and Medical Affairs, Inc. and Medivation, Inc. – PCF Young Investigator Award
Jason A. Efstathiou, MD, DPhil:
Massachusetts General Hospital
Mentor:
Matthew R. Smith, MD, PhD
Project Title:
Predictors of Response and Failure to Radiotherapy for Prostate Cancer in a Randomized Trial
-
Geraldine Gueron
Proteomics is the study of proteins in..
Geraldine Gueron
2013 Stanley Zax-PCF Young Investigator
Geraldine Gueron, PhD:
Iquibicen-Conicet (Argentina)
Mentor:
Elba Vazquez, PhD
Project Title:
Proteome-base biomarkers in prostate cancer: protein profiling using mass spectrometry, bioinformatics based approach and tissue microarray technology
-
Lauren Harshman
Immunotherapy has come of age with the..
Lauren Harshman
2013 PCF Young Investigator
Lauren Harshman, MD
Dana-Farber Cancer InstituteMentors:
Philip Kantoff, MD and Christopher Sweeney, MBBS
Project Title:
Clinical exploration of innovative targeted and immune modulating therapies in prostate cancer
:
-
Emmanuel Antonarakis
Understanding resistance to new treatments for advanced,..
Emmanuel Antonarakis
2013 Steve Wynn-PCF Young Investigator
Emmanuel Antonarakis, MD:
Johns Hopkins University School of Medicine
Mentors:
Michael Carducci, MD and Jun Luo, PhD
Project Title:
Understanding mechanisms of response and resistance to abiraterone (Zytiga) and enzalutamide (Xtandi) in men with metastatic castration-resistant prostate cancer, by interrogation of tumor biopsies for androgen receptor splice variants.
-
Syed Adnan Ali
Over 1 million prostate biopsies are performed..
Syed Adnan Ali
2013 LeFrak Family-PCF Young Investigator
Syed Adnan Ali, MD:
Mount Sinai School of Medicine
Mentor:
Ashutosh Tewari, MD
Project Title:
Intratumor Heterogeneity (ITH) in Prostate Cancer
